OTHER SYNTHETICS BILL STATUS REPORT CARRYOVER, 2014, SPECIAL SESSIONS, AND PROPOSED REGULATIONS

Transcription

1 OTHER SYNTHETICS BILL STATUS REPORT CARRYOVER,, SPECIAL SESSIONS, AND PROPOSED REGULATIONS Research is current through May 13,. This project was supported by Grant No. G1299ONDCP03A, awarded by the Office of National Drug Control Policy. Points of view or opinions in this document are those of the author and do not necessarily represent the official position or policies of the Office of National Drug Control Policy or the United States of Government. 1

2 Bills Bill No. Description Status and Date of Last Action AL HB 480 Adds 4-FA, 4-FMA, 2-FA, MXE, MDC, 2-FMA, 4- MMA, 4-FIC, 3-FMA, MPA, 3-FA, bk-mddma, amfepramone, 3-MMC, MBDB, MPHP, BTCP, MeOPPP, 3-FC, 4-FC, 4-MeMABP, 5-IT, 4-APB, MDAT, 2,5-DMA, 3,4-DMA, 2-AI, MDMAI, 2C-B- FLY, bromo-dragonfly, 3C-B-FLY, 3-MeO-PCE, 4- MeO-PCP, 4-MeO-PCE, 4-MeO-PCB, 3-MeO-PCP, NMT, MiPT, 4-AcO-DiPT, 4-MeO-DMT, 5-AcO-DMT, 5-MeO-DPT, DOC, 25I-NBOMe, 2C-E, 2C-I, 6-APDB, 6-APB, 5-APDB, 5-APB, 2C-T-7, 2C-P, DOB, 2C-B, 2C-C, 2C-T-2, DOI, DOM, SC-H, 25B-NBOMe, 25C- NBOMe, 25E-NBOMe, 25H-NBOMe, BZP, DBZP, TFMPP, 2C-T-4, 2C-T, 2C-D, 2C-N, 5-MeO-DALT, 5- MeO-DIPT, 5-MeO-AMT, 4-AcO-DMT, 4-HO-DET, 4- HO-DIPT, 4-OH-MET, 5-MeO-DET, 5-MeO-MIPT, D2PM, phenazepam, O-DT, pcpp, MBZP, 5-AIA, and class definition AL SB 333 Adds 4-FA, 4-FMA, 2-FA, MXE, MDC, 2-FMA, 4- MMA, 4-FIC, 3-FMA, MPA, 3-FA, bk-mddma, amfepramone, 3-MMC, MBDB, MPHP, BTCP, MeOPPP, 3-FC, 4-FC, 4-MeMABP, 5-IT, 4-APB, MDAT, 2,5-DMA, 3,4-DMA, 2-AI, MDMAI, 2C-B- FLY, bromo-dragonfly, 3C-B-FLY, 3-MeO-PCE, 4- MeO-PCP, 4-MeO-PCE, 4-MeO-PCB, 3-MeO-PCP, NMT, MiPT, 4-AcO-DiPT, 4-MeO-DMT, 5-AcO-DMT, 5-MeO-DPT, DOC, 25I-NBOMe, 2C-E, 2C-I, 6-APDB, 6-APB, 5-APDB, 5-APB, 2C-T-7, 2C-P, DOB, 2C-B, 2C-C, 2C-T-2, DOI, DOM, SC-H, 25B-NBOMe, 25C- NBOMe, 25E-NBOMe, 25H-NBOMe, BZP, DBZP, TFMPP, 2C-T-4, 2C-T, 2C-D, 2C-N, 5-MeO-DALT, 5- MeO-DIPT, 5-MeO-AMT, 4-AcO-DMT, 4-HO-DET, 4- HO-DIPT, 4-OH-MET, 5-MeO-DET, 5-MeO-MIPT, D2PM, phenazepam, O-DT, pcpp, MBZP, 5-AIA, and class definition AZ HB Adds APB, APDB, 5-MeO-aMT, fluoroamphetamine, fluoromethamphetamine, methiopropamine, HO-PCP, MXE, MeO-PCP, methoxyketamine, mitragynine, hydroxymitragynine - Adds class definitions with the following as examples: ACO-DMT, Baeocystine, bromo-dalt, DiPT, DMT, 4/1/ Indefinitely postponed 3/13/ Enrolled; assigned Act number 4/15/ 2

3 DPT, HO-DET, HO-DiPT, HO-DMT, HO-DPT, HO- MET, MeO-DALT, MeO-DET, MeO-DiPT, MeO-DMT, MeO-DPT, MeO-NMT, MET, NMT, Norbufotenin, amino-pcp, BCP, bromo-pcp, BTCP, chloro-pcp, fluoro-pcp, HO-PCP, MeO-PCP, methyl-pcp, nitro- PCP, OXO-PCP, PCE, PCM, PCPY, TCP, TCPY FL HB 697 Adds 25B-NBOMe, 2C-C-NBOMe 4/28/ Ordered enrolled FL SB 780 Adds 25B-NBOMe, 2C-C-NBOMe 4/25/ Substituted by HB 697; laid on table GA HB 835 HI HB 2332 HI SB 2882 Adds 2C-E, 25N-NBOMe, 4-AcO-MET, 2C-N, 5-MeO- MIPT, MXE, MeOPP 2C-N, 2C-P, 25I-NBOMe, 25C-NBOMe, 25B-NBOMe 2C-N, 2C-P, 25I-NBOMe, 25C-NBOMe, 25B-NBOMe 4/15/ 2/25/ Committee recommends measure be deferred 4/30/ ID SB 1379 Adds DOB, DOC, 2C-B, 25B-NBOMe 4/4/ effective July 1, IL HB 5526 Adds kratom 5/7/ Passed House; in Senate IL SB 3275 Adds 25I-NBOMe 5/12/ House amendment referred to 3

4 IN SB Amends statute regarding Attorney General s access to documents necessary for investigations to delete reference to synthetic drugs and replace it with Schedule I controlled substance or controlled substance lookalike with the same amendment for statutes involving revocation of certain certificates - Amends penalty provisions - Creates new definition of controlled substance lookalike and deletes definitions of synthetic drug and synthetic drug lookalike substance - Adds 6-APB, 7-hydroxymitragynine, MXE, mitragynine, 25I-NBOMe, 2C-C-NBOMe - Adds new statute regarding suspension of retail merchant certificate for certain drug related infractions 2/10/ House IA HF 2355 Adds kratom 3/14/ IA SF 2121 Adds 5-MeO-DMT, 25I-NBOMe, 25C-NBOMe, 25B- NBOMe KS HB 2298 KS HB 2701 KS SB 437 2C-N, 2C-P, 5-MeO-DMT, 25I-NBOMe, 25C-NBOMe, 25B-NBOMe, 25H-NBOMe 2C-N, 2C-P, 5-MeO-DMT, 25I-NBOMe, 25C-NBOMe, 25B-NBOMe, 25H-NBOMe 2C-N, 2C-P, 5-MeO-DMT, 25I-NBOMe, 25C-NBOMe, 4/3/ Governor 4/18/ July 1, 2/28/ Stricken from calendar 3/17/ Scheduled for hearing 25B-NBOMe, 25H-NBOMe LA HB 19 Adds mitragynine, 7-hydroxymitragynine 3/10/ MN HF 2402 Adds MPHP 5/9/ Conferees appointed MN HF 2545 Adds MPHP 3/19/ Committee report to adopt as amended MN SF 1484 Adds MPHP 4/30/ First reading in House MN SF 2135 Adds MPHP 3/27/ 4

5 Committee report to pass as amended MS HB 7 Adds 2C-I, 25I-NBOMe, phenazepam 3/4/ MS HB 50 Adds 2C-I, 25I-NBOMe, phenazepam 2/4/ MS HB 1231 MS SB 2005 MS SB 2323 NM SB 127 NY AB 6607 NY SB C-N, 2C-P 2C-N, 2C-P Adds 2C-E, 2C-D, 25B-NBOMe, 2C-I, 25C-NBOMe, 2C-T-2, 25I-NBOMe, 2C-T-4, 2C-H, 2C-N, 2C-P Adds 2,5-DMA, alpha-ethyltryptamine, 2C-T-7, 5-MeO- DiPT Adds 2C-B-FLY, 3C-B-FLY, bromo-dragonfly, 2C-E, 2C-D, 2C-C, 5-MeO-DALT, 5-MeO-DIPT, 3-MeO-PCE, 4-MeO-PCP, 5-IAI, 6-APB, 2-AI Adds 2C-B-FLY, 3C-B-FLY, bromo-dragonfly, 2C-E, 2C-D, 2C-C, 5-MeO-DALT, 5-MeO-DIPT, 3-MeO-PCE, 4-MeO-PCP, 5-IAI, 6-APB, 2-AI 4/17/ Approved by effective July 1, 2/4/ 2/4/ Died 4/12/ 2/6/ Amend and recommit to NY SB 6951 Adds 25I-NBOMe, 2C-1, 25C-NBOMe, 2C-B-NBOMe 4/7/ OK HB 2666 Adds 25B-NBOMe, mitragynine, 7-hydroxymitragynine 4/25/ effective November 1, UT HB 30 Adds 25H-NBOMe 3/20/ 5

6 WV HB 4208 WV HB C-P, 2C-T-7, 5-MeO-DMT, 5-MeO-DiPT 2C-P, 2C-T-7, 5-MeO-DMT, 5-MeO-DiPT 4/1/ Approved by effective June 6, 1/21/ WV SB 1 Adds 2C-T-7, 5-MeO-DMT, 5-MeO-DiPT 1/29/ WI SB 325 Adds MXE, DOI, DOC, 2C-E, 2C-D, 2C-C, 2C-T-2, 2C- T-4, 2C-H, 2C-N, 2C-P, 5-MeO-DALT, 5-APB, 6-APB, 5-APDB, 6-APDB, 5-IAI, 3-MMC, MDAI, BTCP WY HB 11 2C-N, 2C-P, 25B-NBOMe, 25C-NBOMe, 25I-NBOMe 4/24/ effective April 25, 3/11/ Regulations Reg. No. Description Status and Date of Last Action AL Adds 4-FA, 4-FMA, 2-FA, MXE, 2-FMA, 4-MMA, 3- FMA, MPA, 3-FA, 3-MeOMC, MPHP, BTCP, 4-APB, MDAT, 2,5-DMA, 3,4-DMA, 2-AI, MDMAI, 2C-T-1, 2C-B-Fly, 25D-NBOMe, 25G-NBOMe, Bromo- DRAGONfly, 3C-B-Fly, 3-MeO-PCE, 4-MeO-PCP, 4- MeO-PCE, 3-MeO-PCP, NMT, 4-MeO-DMT, 5-AcO- DMT, 5-MeO-DPT, DOC, 25I-NBOMe, 2C-E, 2C-I, 6- APDB, 6-APB, 5-APDB, 5-APB, 2C-T-7, 2C-P, DOB, 2C-B, 2C-C, 2C-T-2, DOI, DOM, 2C-H-, 25B-NBOMe, 25C-NBOMe, 25E-NBOMe, 2-EMC, 25H-NBOMe, TFMPP, 2C-T-4, 2C-T, 2C-D, 2C-N, 5-MeO-DALT, 5- MeO-DIPT, 5-MeO-AMT, 4-AcO-DMT, 4-HO-DIPT, 5- MeO-MIPT, 4-AcO-MIPT, DPT, DIPT, 4-MeO-MIPT NV Adds 4-AcO-DMT, TFMPP, and NBOMe and derivatives, including 25H-NBOMe, 25B-NBOMe, 25C- NBOMe, 25D-NBOMe, 25E-NBOMe, 25I-NBOMe, 25N-NBOMe, 25P-NBOMe, 25T2-NBOMe, 25T4- NBOMe, 25T7-NBOMe 4/30/ Proposed rules 3/17/ LCB Drafts NM Adds 25B-NBOMe, 25C-NBOMe, 25I-NBOMe 3/31/ 6

7 Notices of rule making and proposed rules TX Adds 25I-NBOMe, 25C-NBOMe, 25B-NBOMe 3/21/ In addition WY Adds 25B-NBOMe, 25C-NBOMe, 25I-NBOMe 12/27/2013 Notice of Intent to adopt rule Highlighted text indicates the bill or regulation has been approved. Red text indicates the legislature is no longer in session. 7